Publication | Closed Access

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

ThrombosisEndpoint TrialTenecteplase Versus AlteplaseIschemic StrokeCardiovascular DiseaseMedicineCerebrovascular DiseaseRehabilitationNeurologyCerebrovascular InterventionCerebral Blood FlowPublic HealthStrokeIschemic SyndromePhase 3Reperfusion Injury